[{"Assets_0_Q3_USD":57426795.0,"EarningsPerShareBasic_3_Q3_USD":-0.13,"EarningsPerShareBasic_1_Q3_USD":-0.03,"EarningsPerShareDiluted_3_Q3_USD":-0.13,"EarningsPerShareDiluted_1_Q3_USD":-0.03,"NetIncomeLoss_3_Q3_USD":-3932712.0,"NetIncomeLoss_1_Q3_USD":-789889.0,"StockholdersEquity_0_Q3_USD":32813077.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30983271.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":30991247.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":30983271.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":30991247.0,"Ticker":"VERU","CIK":"863894","name":"VERU INC.","OfficialName":"Veru Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1011836411.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]